Pharminox makes board appointment
This article was originally published in Scrip
Executive Summary
Pharminox has appointed Dr Marc Hummersone to its board of directors as research director. Dr Hummersone joined the company from KuDOS Pharmaceuticals in April 2008 as head of chemistry. The UK-based cancer drug discovery and development company has also announced that Professor Malcolm Stevens is standing down from the board and as chief scientific officer, and will take up the honorary position of CSO Emeritus.